Development of a new thiol-reactive prosthetic group for site-specific labeling of biomolecules with radioactive iodine

Bioorg Med Chem Lett. 2018 Sep 15;28(17):2875-2878. doi: 10.1016/j.bmcl.2018.07.028. Epub 2018 Jul 18.

Abstract

In this report, we describe the radiosynthesis of a new thiol-targeting prosthetic group for efficient radioactive iodine labeling of biomolecules. Radioiodination using the precursor 3 was performed to obtain 125I-labeled tetrazole 4b with high radiochemical yield (73%) and radiochemical purity. Using the radiolabeled 4b, a single free cysteine containing peptide and human serum albumin were labeled with 125I in modest-to-good radiochemical yields (65-99%) under mildly reactive conditions. A biodistribution study of [125I]7 in normal ICR mice exhibited lower thyroid uptake values than those of 125I-labeled human serum albumin prepared via a traditional radiolabeling method. Thus, [125I]7 could be employed as an effective radiotracer for molecular imaging and biodistribution studies. The results clearly demonstrate that 4b has the potential to be effectively implemented as a prosthetic group in the preparation of radiolabeled biomolecules.

Keywords: Biodistribution; Radioactive iodine; Radiolabeling; Radiopharmaceutical; Site-specific reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Iodine Radioisotopes / chemistry*
  • Molecular Structure
  • Peptides / chemistry*
  • Serum Albumin, Human / chemistry*
  • Structure-Activity Relationship
  • Sulfhydryl Compounds / chemical synthesis
  • Sulfhydryl Compounds / chemistry
  • Sulfhydryl Compounds / pharmacology*

Substances

  • Iodine Radioisotopes
  • Peptides
  • Sulfhydryl Compounds
  • Serum Albumin, Human